Comparison of body mass index (BMI) with the CUN-BAE body adiposity estimator in the prediction of hypertension and type 2 diabetes by Martín, Vicente et al.
RESEARCH ARTICLE Open Access
Comparison of body mass index (BMI) with
the CUN-BAE body adiposity estimator in
the prediction of hypertension and type 2
diabetes
Vicente Martín1,2, Verónica Dávila-Batista1,12*, Jesús Castilla2,3, Pere Godoy2,4, Miguel Delgado-Rodríguez2,5,
Nuria Soldevila2, Antonio J. Molina1, Tania Fernandez-Villa1, Jenaro Astray6, Ady Castro7, Fernando González-Candelas2,8,
José María Mayoral9, José María Quintana2,10, Angela Domínguez2,11 and CIBERESP Cases and Controls in Pandemic
Influenza Working Group, Spain
Abstract
Background: Obesity is a world-wide epidemic whose prevalence is underestimated by BMI measurements, but
CUN-BAE (Clínica Universidad de Navarra - Body Adiposity Estimator) estimates the percentage of body fat (BF)
while incorporating information on sex and age, thus giving a better match. Our aim is to compare the BMI and
CUN-BAE in determining the population attributable fraction (AFp) for obesity as a cause of chronic diseases.
Methods: We calculated the Pearson correlation coefficient between BMI and CUN-BAE, the Kappa index and the
internal validity of the BMI. The risks of arterial hypertension (AHT) and diabetes mellitus (DM) and the AFp for
obesity were assessed using both the BMI and CUN-BAE.
Results: 3888 white subjects were investigated. The overall correlation between BMI and CUN-BAE was R2 = 0.48,
which improved when sex and age were taken into account (R2 > 0.90). The Kappa coefficient for diagnosis of
obesity was low (28.7 %). The AFp was 50 % higher for DM and double for AHT when CUN-BAE was used.
Conclusions: The overall correlation between BMI and CUN-BAE was not good. The AFp of obesity for AHT and
DM may be underestimated if assessed using the BMI, as may the prevalence of obesity when estimated from the
percentage of BF.
Keywords: Obesity, Body mass index, Body fat, CUN-BAE, Population attributable fraction, Hypertension, Diabetes
mellitus
Background
Obesity is seen as an emerging epidemic around the
world because it represents a growing threat to the
health of the population. It is a complex disease consist-
ing of an excess or abnormal distribution or both of adi-
pose tissue, giving rise to metabolic and endocrine
alterations and changes in the immune system, resulting
in increased morbidity and mortality and a lower life
expectation [1, 2]. Moreover, excess body fat (BF) is
known to be associated with cardiovascular diseases and
diabetes [3].
The body mass index (BMI) is the most frequently
used measurement for diagnosing obesity, because of its
simplicity and reliability. However, the BMI underesti-
mates the prevalence of obesity by 50 %, in comparison
with direct measurement techniques of adipose; its rela-
tionship with adiposity is influenced by age, sex and race
[1, 4–7].
In this regard, an alternative for whites is the CUN-
BAE (Clínica Universidad de Navarra - Body Adiposity
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Estimator), which gives a closer correlation between adi-
posity and cardiovascular factors than BMI, improving
our understanding of the impact of obesity levels on
these chronic diseases [8].
Our aim is to compare the BMI and CUN-BAE and
evaluation the population attributable fraction (AFp) for
obesity as a cause of hypertension and type 2 diabetes.
Methods
Population studied
The present study incorporated all the white patients
taking part in the cross-sectional project concerning the
Risk Factors of Infuenza A(H1N1) in the 2009–10 and
2010–11 seasons aged over eighteen with a BMI ≥
18.5 kg/m2, with the exception of pregnant women. The
project involved twenty-nine hospitals in seven Spanish
autonomous regions and nine research groups in CIBER-
ESP, the Spanish Consortium for Biomedical Research in
Epidemiology and Public Health [9].
Anthropometrical measurements
The body mass index (BMI) was calculated in the stand-
ard way as kg/m2. Patients were classified by BMI accord-
ing to the criteria of the World Health Organization
(WHO) and the Spanish Society for the Study of Obesity,
with obesity being taken to be a BMI of 30 kg/m2 or more
for both sexes [10, 11].
The CUN-BAE figure was then calculated, using the
following equation [8]:
% BF ¼ ‐44:988 þ ð0:503  ageÞ þ ð10:689  sexÞ
þ ð3:172  BMIÞ ‐ ð0:026  BMI2Þ
þ ð0:181  BMI  sexÞ ‐ ð0:02  BMI  ageÞ
‐ 0:005  BMI2 sexÞ þ 0:00021  BMI2 ageÞ
where age was in years, and sex was coded as 0 for men
and 1 for women. Obesity was taken to be a percentage of
BF ≥ 25 % in males and ≥ 35 % in women, increments of
5 % being used to divide categories [8, 12, 13].
Subjects were defined as hypertensive (AHT) or as
having type 2 diabetes mellitus (DM) if they had previ-
ously been diagnosed for either.
Statistical analyses
Agreement between BMI and CUN-BAE was assessed
by means of the Pearson correlation coefficient. The
Kappa coefficient and its index of coincidence at 95 %
were calculated so as to classify patients as obese or not
using both methods of determining obesity. All the ana-
lyses involved grouping by sex and into the two age
bands of under 50 and 50 plus.
Association of type 2 diabetes mellitus (DM) or arter-
ial hypertension (AHT) to BF was assessed using the
two methods for calculating body fat. The comparative
standard adopted was the normal weight category [2, 8],
and the level of risk (crude odds ratio, cOR) was calcu-
lated for each of the distribution categories. By means of
a logistic regression model adjusted odds ratio (aOR)
figures were reckoned for the risk of AHT and DM by
including in the model details of education, marital sta-
tus and tobacco and alcohol use. Age was factored into
the BMI analyses, but not into CUN-BAE, which already
includes it. All these analyses were grouped by sex.
Calculation of the population attributable fraction
(AFp) for AHT and DM in the BMI and CUN-BAE cat-
egories was on the basis of the following formula
expressed as a percentage [14]:
1−
Xk
l
pd=aORð Þ
where pd is the proportion of those suffering from the
ailments at the level of exposure, and aOR is the ad-
justed odds ratio.
Data analysis was performed with the Stata/SE 13 soft-
ware package.
Data confidentiality and ethical considerations
All information collected was treated as confidential
under the observational studies law. The study was
approved by the Ethics Committee of the hospitals in-
volved: Clinical Research Ethics Committee, Hospital
Costa del Sol; Autonomous Clinical Trials Committee of
Andalusia; Clinical Research Ethics Committee, Complejo
Asistencial Universitario de León; Clinical Research Ethics
Committee, Municipal Institute of Healthcare (CEIC-
IMAS); Clinical Research Ethics Committee, Corporación
Sanitaria ParcTaulí of Sabadell; Research Committee, Sant
Joan de Déu University Hospital; Clinical Research Ethics
Committee, Basque Country; Clinical Research Ethics
Committee, Doctor Peset Univeristy Hospital, Valencia;
and, Clinical Research Ethics Committee, Clinical Re-
search Ethics Committee, General Directorate of Public
Health, Valencia. Written informed consent was obtained
from all patients.
Results
A total of 3888 patients were studied: 2033 men with an
average age of 50.7 years, and 1855 women with an aver-
age age of 49.6 years. The average BMI was 26.9 kg/m2
for the men and 26.3 kg/m2 for the women. The average
CUN-BAE was 27.1 % of BF for the men and 37.6 % for
the women.
Figure 1 shows the distribution of BMI and CUN-
BAE. From the four groupings depending on sex and
age. The correlation between BMI and CUN-BAE was
low (R2 = 0.48), but increased considerably when sex
was taken into account (R2 above 0.88 in both sexes).
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This improvement was even greater when age (under
50 or 50 plus) was also considered, when R2 was greater
than 0.92 (Table 1).
The degree of agreement measured by the Kappa coef-
ficient for diagnosis of obesity was low (28.7 %), similar
for both sexes and somewhat better for those under 50
than the others. This low level of agreement with BMI
explains the different prevalence of obesity noted in ac-
cordance with the criterion used. In all cases the
prevalence of obesity as based on the estimation of body
fat CUN-BAE is three times higher than the BMI would
suggest.
Table 2 and Fig. 2 show that as the figures for both
BMI and CUN-BAE increased, so did the prevalence of
AHT and the aOR values. However, this gradient was
more evident with CUN-BAE than with BMI, basically
owing to a lesser prevalence of AHT in the normal
weight group based on the criterion of estimated body
Fig. 1 Distribution for CUN-BAE and BMI. Straight-Line Equation and Correlation by Sex and Age
Table 1 Correlation and degree of agreement between CUN-BAE and BMI and prevalence of obesity according to sex and age
groups
N R2 Obesitya Level of
Agreement
Kappa Kappa(%) CI
95 %BMI CUN-BAE
n % n %
Men
Total 2033 0.877 435 21.4 1254 61.7 59.7 28.9 26.3 31.6
Under 50 971 0.957 183 18.8 412 42.4 76.4 47.9 42.9 53.0
50 or over 1062 0.940 252 23.7 842 79.3 44.4 15.0 12.6 17.5
Women
Total 1855 0.915 395 21.3 1150 62.0 59.3 28.5 25.7 31.2
Under 50 921 0.926 134 14.5 367 39.8 74.7 40.9 35.6 46.2
50 or over 934 0.919 261 27.9 783 83.8 44.1 13.9 11.4 16.4
aObesity: BMI ≥ 30 kg/m2, CUN-BAE ≥25 % body fat in men and 25 % in women
Abbreviations: R2 square of the sample correlation coefficient, BMI body mass index, CUN-BAE Clínica Universidad de Navarra - Body Adiposity Estimator
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Table 2 Distribution of prevalence and risk of hypertension by sex according to BMI and CUN-BAE
N n Prev cOR CI 95 % aORa CI 95 % AFp(%)
Men
BMI (kg/m2)
18.5–24.9 749 152 20.29 1 1 37.00
25–29.9 849 254 29.92 1.68 1.33–2.11 1.33 1.02–1.74
30–34.9 328 169 51.52 4.17 3.15–5.53 3.93 2.84–5.44
35–39.9 74 37 50.00 3.93 2.40–6.40 4.50 2.56–7.89
≥40 33 16 48.48 3.70 1.83–7.49 8.66 3.80–19.39
CUN-BAE (%BF)
≤19.9 258 21 8.14 1 1 74.03
20–24.9 521 79 15.16 2.02 1.22–3.35 1.67 1.00–2.80
25–29.9 631 208 32.96 5.55 3.45–8.93 3.80 2.32–6.21
30–34.9 415 199 47.95 10.40 6.40–16.90 6.80 4.11–11.25
≥35 208 121 58.17 15.70 9.29–26.52 11.24 6.54–19.31
Women
BMI (kg/m2)
18.5–24.9 895 119 13.30 1 1 45.32
25–29.9 565 180 31.86 3.05 2.35–3.96 1.99 1.46–2.71
30–34,9 259 110 42.47 4.81 3.52–6.58 2.73 1.87–3.98
35–39.9 86 45 52.33 7.15 4.50–11.39 4.93 2.83–8.58
≥40 50 26 52.00 7.06 3.93–12.71 7.71 3.80–15.64
CUN-BAE (%BF)
≤29.9 303 9 2.97 1 1 89.14
30–34.9 402 36 8.96 3.21 1.52–6.78 2.97 1.34–6.57
35–39.9 464 108 23.28 9.91 4.93–19.90 7.82 3.71–16.49
40–44.9 389 165 42.42 24.06 12.03–48.12 16.10 7.63–33.99
≥45 297 162 54.55 39.20 19.44–79.06 23.30 10.93–49.69
aaOR: BMI (age, educational level, marital status, tobacco and alcohol use); CUN-BAE (educational level, marital status, tobacco and alcohol use)
Abbreviations: CI confidence interval, aOR adjusted odds ratio, AFp population attributable fraction, BMI body mass index, CUN-BAE Clínica Universidad de Navarra
- Body Adiposity Estimator, BF body fat
Fig. 2 Distribution of Number of Cases of hypertension and aOR, by sex. Legends: Categories of Adiposity: With BMI (C1: 18,5–24.9, C2:
25–29.9, C3: 30–34,9, C4: 35–39.9, C5: ≥ 40 Kg/m2) with CUN-BAE men (C1: ≤ 19.9, C2: 20–24.9, C3: 25–29.9, C4: 30–34.9, C5: ≥ 35 %BF)
and women (C1: ≤ 29.9, C2: 30–34.9, C3: 35–39.9, C4: 40–44.9, C5: ≥ 45 %BF)
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fat (8.1 % and 3.0 % in men and women respectively)
than when based on BMI (20.3 % and 13.3 % in men
and women respectively). The AFp of AHT assigned to
the two methods of assessing adiposity was found to be
double for both men and women for CUN-BAE in com-
parison with BMI (37.0 % and 45.4 % with BMI; 74.0 %
and 89.1 % with CUN-BAE for men and women, re-
spectively). In men this difference is due to the differing
distributions of cases with the two methods of evaluating
adiposity, and a mixture of this and differences in risks
in the case of women.
Table 3 and Fig. 3 show how prevalence and aOR
figures for DM increase according to the category of
obesity in both sexes for CUN-BAE and in women for
BMI. This gradient is more obvious with CUN-BAE than
with BMI for men and similar for the two among
women, although they yield different distributions. Re-
garding the AFp of DM the CUN-BAE almost tripled
the attributable percentage in comparison with BMI in
men (71.54 % as opposed to 26.19 %), while for women
the figure was 50 % higher (65.19 % as opposed to
40.38 %).
Discussion
The correlation found between BMI and CUN-BAE in
overall analyses was not good (R2 = 0.48). This coincides
with the findings of Romero-Corral et al. and Sardinhha
et al., who also noted a low overall agreement (R2 of
0.40 to 0.47) between BMI and the percentage of BF
assessed by bio-electric impedance [7, 15]. This poor
correlation is explained by the fact that adiposity is
dependent upon sex and age. It is well known that with
the same BMI women and more elderly subjects have a
greater percentage of BF [15–18]. This same fact also ex-
plains the improvement in correlation when sex, age, or
both are factored into the figures. This was also
Table 3 Distribution of prevalence and risk of diabetes II by sex according to BMI and CUN-BAE, 2009–2011
N n Prev cOR CI 95 % aORa CI 95 % AFp(%)
MEN
IMC
18.5–24.9 749 73 9.75 1 1 26.19
25–29.9 849 113 13.31 1.42 1.04–1.94 1.13 0.80–1.58
30–34,9 328 79 24.09 2.94 2.07– 4.17 2.37 1.62–3.48
35–39.9 74 21 28.38 2.97 1.80–4.92 3.19 1.83–5.55
≥40 33 5 15.15
CUN-BAE
≤19.9 258 9 3.49 1 1 71.54
20–24.9 521 35 6.72 1.99 0.94–4.21 1.66 0.78–3.55
25–29.9 631 95 15.06 4.90 2.44–9.87 3.49 1.70–7.16
30–34.9 415 87 20.96 7.34 3.62–14.86 4.91 2.37–10.14
≥35 208 65 31.25 12.58 6.08–26.01 8.34 3.96–17.56
WOMEN
IMC
18.5–24.9 895 50 5.59 1 1 40.38
25–29.9 565 76 13.45 2.63 1.81–3.82 1.78 1.20–2.64
30–34,9 259 45 17.37 3.55 2.31–5.46 2.09 1.33–3.31
35–39.9 86 21 24.42 5.46 3.09–9.64 3.44 1.86–6.35
≥40 50 19 38,0 10.36 5.47–19.61 8.13 4.08–16.18
CUN-BAE
≤29.9 303 10 3.3 1 1 65.19
30–34.9 402 23 5.72 1.78 0.83–3.79 1.64 0.76–3.54
35–39.9 464 36 7.76 2.46 1.20–5.04 1.86 0.89–3.87
40–44.9 389 61 15.68 5.45 2.74–10.83 3.47 1.69–7.13
≥45 297 81 27.27 10.99 5.57–21.69 6.49 3.16–13.3
aaOR: BMI (age, educational level, marital status, tobacco and alcohol use); CUN-BAE (educational level, marital status, tobacco and alcohol use)
Abbreviations: CI confidence interval, aOR adjusted odds ratio, AFp population attributable fraction, BMI body mass index, CUN-BAE Clínica Universidad de Navarra
- Body Adiposity Estimator, BF body fat
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observed by Gallagher et al., who found an overall cor-
relation R2 = 0.26, but when sex and age were taken into
account the correlation was much better, with values for
R2 of up to 0.67 [18]. On this point, it should be noted
that there was a good coincidence between the correl-
ation figures obtained in studies comparing BMI with
directly measured body fat and body fat estimated with
CUN-BAE [8, 18–20].
Regarding the classification of obesity, this study opted
for BMI ≥ 30 kg/m2, regardless of sex or age, since this is
the criterion recommended by the WHO, the most ex-
tensively used world-wide and by scientific associations
in Spain [2, 11]. The cut-off point for CUN-BAE was
based on the criteria indicated by the authors who de-
scribed the formula for calculating it, and was thus coin-
cident with recommendations in other studies [12, 21].
On the basis of these norms, there is a low level of
agreement in classification of obesity between BMI and
the percentage of BF estimated by CUN-BAE, with a
Kappa coefficient of 28.7 %. In other publications the
Kappa between BMI and percentage of BF was similarly
low in women (between 15 % and 30 %), while in men
greater variations were noted (between 8 % and 70 %).
In addition to BMI as compared to the percentage of
BF, prevalence of obesity estimated with CUN-BAE
(61.8 %) was much higher than with BMI (21.35 %). This
coincided with other publications in which the preva-
lences of obesity estimated through the percentage of BF
were almost double those yielded by BMI [4, 22] or even
up to six times higher [23].
Diabetes and AHT are common ailments clearly re-
lated to obesity as a risk factor, which is why we studied
their association with the two ways of assessing body fat,
to find that estimates of BF according to CUN-BAE were
more clearly related to AHT and DM than results from
BMI, just as was noted by Dervaux et al. in the assess-
ment of body fat percentages [24]. The main reason for
this clearer association lies in the lower prevalence of
AHT and DM in the normal weight grouping as assigned
on the criterion of estimated body fat than as assigned
by BMI. Furthermore, the greater number of instances
of AHT and DM are to be found in lower-weight cat-
egories according to BMI, while with CUN-BAE they are
present in a smaller number of individuals. Other studies
have also shown a better correlation of CUN-BAE with
other biological markers of cardiovascular and metabolic
diseases [8, 25].
The final result, the disparity in aOR and essentially in
the distribution of patients according to BMI or CUN-
BAE, comes down to the great differences observed in
the attributable portion of the population for AHT or
DM on the basis of quantity of body fat. Indeed, the fact
that the majority of patients had high percentage of BF,
while with BMI they were assigned to lower categories,
goes a long way towards explaining the total number of
cases attributed to higher than normal weight. In almost
all instances the classification of patients according to
CUN-BAE almost doubled the AFp relative to classifica-
tion in accordance with BMI. It may also be of some
relevance that the reference group with BMI (normal
weight) is a very broad grouping in which risk may be
expected not to be homogeneous, in the sense that indi-
viduals in the upper part of the range might present a
risk more like that of the over-weight than that of the
lower part of the normal weight spectrum. All of this
may cast a doubt upon estimates made of portions or
fractions of the population and cases of AHT and DM
attributable to obesity as a function of BMI [26, 27], so
that the real impact of obesity in these pathologies may
be much greater than assumed.
CUN-BAE has been proposed as a substitute for the
BMI. Few studies have assessed its usefulness for classi-
fying obesity or determining obesity-related cardiovascu-
lar risks. Nevertheless such studies as have been carried
Fig. 3 Distribution of the Number of Cases of Diabetes and aOR, by sex. Legends: Categories of Adiposity: With BMI (C1: 18,5–24.9, C2: 25–29.9,
C3: 30–34,9, C4: 35–39.9, C5: ≥ 40 Kg/m2) with CUN-BAE men (C1: ≤ 19.9, C2: 20–24.9, C3: 25–29.9, C4: 30–34.9, C5: ≥ 35 %BF) and women (C1: ≤
29.9, C2: 30–34.9, C3: 35–39.9, C4: 40–44.9, C5: ≥ 45 %BF)
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out report the same phenomenon as we do here, show-
ing that CUN-BAE classes a greater number of subjects
as obese and therefore greatly reduces the number of in-
dividuals in the reference category [28–30].
One possible limitation is that the highest adiposity
category in men was established to avoid a sample size
problem. Furhtermore, in our findings the sample may
not have been representative of the population as a
whole: the subjects were patients admitted to hospital or
making use of health services for various reasons, so the
prevalence of obesity and of AHT and DM was higher
than in the population in general [31, 32]. However, the
aOR observed in relation to BMI for AHT and DM was
very similar to that reported in another study [26].
Conclusions
Although the overall correlation between BMI and the
BF estimator was not good, it improved when sex and
age were taken into account.
There is a low level of agreement in accordance with
the criterion used. The prevalence of obesity as based on
estimation of body fat is the three times higher than the
BMI would suggest, which could lead to an underesti-
mation of the prevalence of obesity.
CUN-BAE showed links with hypertension and dia-
betes mellitus, and presented a better gradient than BMI
did. The AFp for AHT was double when assessed with
CUN-BAE as compared to BMI, while for DM it was
more than 50 % higher. This brings into question the re-
liability of calculations undertaken to assess the impact
of obesity on thesepathologies.
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